# Invitae
> Invitae is a medical genetics company that specializes in genetic testing for a wide range of clinical applications, including oncology, cardiology, and reproductive health. The company aims to integrate genetic information into routine medical practice by providing comprehensive, high-quality, and affordable testing services. In 2024, the company entered Chapter 11 bankruptcy and sold the majority of its assets to Labcorp.
- URL: https://optimly.ai/brand/invitae-invitae
- Slug: invitae-invitae
- BAI Score: 42/100
- Archetype: Under Scrutiny
- Category: Healthcare
- Last Analyzed: March 11, 2026
## Competitors
- Guardant Health (https://optimly.ai/brand/guardant-health)
- Labcorp (https://optimly.ai/brand/labcorp)
- Myriad Genetics, Inc. (https://optimly.ai/brand/myriad-genetics)
- Natera (https://optimly.ai/brand/natera)
## AI-Suggested Alternatives
- Clinical Diagnosis Only (https://optimly.ai/brand/clinical-diagnosis-only)
## Buyer Intent Signals
Problems: Clinical Diagnosis Only: Patients and providers may rely on medical history and physical exams without specific genetic data. | In-house Hospital Labs: Utilizing hospital-based genetic counselors and internal pathology labs to run specialized tests. | Specialized Genetics Agencies: Hiring specialized genetic consulting firms to manage testing workflows and interpretation.
Solutions: best medical genetic testing companies | hereditary cancer screening providers | affordable pharmacogenomics testing | carrier screening for pregnancy costs | clinician portal for genetic results